Sabo, A.-N.; Jannier, S.; Becker, G.; Lessinger, J.-M.; Entz-Werlé, N.; Kemmel, V.
Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology. Pharmaceutics 2021, 13, 470.
https://doi.org/10.3390/pharmaceutics13040470
AMA Style
Sabo A-N, Jannier S, Becker G, Lessinger J-M, Entz-Werlé N, Kemmel V.
Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology. Pharmaceutics. 2021; 13(4):470.
https://doi.org/10.3390/pharmaceutics13040470
Chicago/Turabian Style
Sabo, Amelia-Naomi, Sarah Jannier, Guillaume Becker, Jean-Marc Lessinger, Natacha Entz-Werlé, and Véronique Kemmel.
2021. "Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology" Pharmaceutics 13, no. 4: 470.
https://doi.org/10.3390/pharmaceutics13040470
APA Style
Sabo, A. -N., Jannier, S., Becker, G., Lessinger, J. -M., Entz-Werlé, N., & Kemmel, V.
(2021). Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology. Pharmaceutics, 13(4), 470.
https://doi.org/10.3390/pharmaceutics13040470